Recent news on Rosiglitazone Maleate

EMEA Statement On Recent Publication On Cardiac Safety Of ...  -  25 May 2007
Medical News Today (press release),...maleate) Tablets, Avandamet (rosiglitazone maleate and metformin hydrochloride) Tablets, and Avaglim (rosiglitazone maleate and glimepiride) Tablets are

US research on diabetes drug Avandia has little effect in China  -  25 May 2007
Interfax.cn (subscription),Avandia, known by its generic name as rosiglitazone maleate, has been widely used in the treatment of type 2 diabetes. US researchers reported Monday that

Potential Safety Issue with Avandia  -  May 23, 2007
Facts and Comparisons,There is a potential safety issue related to GlaxoSmithKline’s Avandia (rosiglitazone maleate) based on safety data from a pooled analysis of controlled

GlaxoSmithKline says stands firm behind safety of Avandia ...  -  May 21, 2007
Forbes,...of Medicine regarding the drug Avandia (rosiglitazone maleate), which it calls 'a widely-used and highly-effective treatment for type two diabetes.'

GlaxoSmithKline responds to NEJM article on Avandia  -  May 22, 2007
PipelineReview.com (press release),GlaxoSmithKline today issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia® (rosiglitazone maleate),

GlaxoSmithKline Strongly Defends its Record on Avandia  -  May 21, 2007
PR Newswire (press release),Avandia(R) (rosiglitazone maleate): The suggestion that GlaxoSmithKline has placed patients at risk and attempted to silence independent investigation

Rosiglitazone Linked to Fracture Risk in Women  -  Feb 21, 2007
Medscape (subscription)February 21, 2007 — The risk for upper arm, hand, or foot fractures may be increased in women receiving rosiglitazone maleate vs metformin HCl or glyburide

Rosiglitazone linked to fracture risk in women  -  Feb 21, 2007
TheHeart.Org,Rockville, MD - The risk for upper-arm, hand, or foot fractures may be increased in women receiving rosiglitazone maleate (Avandia, GlaxoSmithKline) vs

Emirates Diabetes Society Warns: Untreated diabetes can lead to ...  -  Jan 9, 2007
Al-Bawaba,This study demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32

Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More ...  -  Dec 4, 2006
PR Newswire (press release),Avandia (rosiglitazone maleate) Indication & Important Safety Information Avandia, along with diet and exercise, helps improve blood sugar control.

Landmark Study Shows Avandia(R) (rosiglitazone Maleate) Is More ...  -  Dec 5, 2006
Medical News Today (press release),Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate) reduced the risk of

Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More ...  -  Dec 4, 2006
PR Newswire (press release),4 /PRNewswire/ -- Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate)

Emirates Diabetes Society Warns: Untreated diabetes can lead to ...  -  Dec 25, 2006
Al-Bawaba,This study demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32

Landmark study shows Avandia(R) controls type 2 diabetes longer ...  -  Dec 4, 2006
CNW Telbec (Communiqués de presse),25) Important Information regarding Avandia (rosiglitazone maleate) Rosiglitazone maleate (Avandia(R)) is indicated for use alone, or in combination with

Landmark study shows Avandia® is more effective than metformin or ...  -  Dec 5, 2006
PipelineReview.com (press release),2006 | Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia® (rosiglitazone maleate) reduced the

Sección internacional  -  Dec 4, 2006
Bolsamania.com,...(PRN) - Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type

Drug can help reduce risk of Type 2 diabetes  Oct 15, 2006
The "Diabetes REduction Assessment with ramipril and rosiglitazone Medication" or DREAM study found that the drug rosiglitazone maleate was able to reduce the ... -Manila Bulletin, FDA Approvals: Januvia  Oct 19, 2006
The once-daily agent can be used alone or in combination with metformin or the thiazolidinediones pioglitazone HCl and rosiglitazone maleate when treatment ... -Medscape (subscription) Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression ...  Sep 17, 2006
15 /PRNewswire/ -- In the largest completed diabetes-prevention trial to date, Avandia(R) (rosiglitazone maleate) reduced the risk of developing type 2 ... -Drug Newswire

Avandia(R) (rosiglitazone Maleate) Reduced Risk Of Progression ...  Sep 16, 2006
In thelargest completed diabetes-prevention trial to date, Avandia(R) (rosiglitazone maleate) reduced the risk of developing type 2 diabetes by 62 percent ... -Medical News Today

Avandia (rosiglitazone maleate) Reduced Risk of Progression From ...  Sep 15, 2006
MALMOE, Sweden, September 15, 2006 /PRNewswire/ -- In the largest completed diabetes-prevention trial to date, Avandia(R) (rosiglitazone maleate) reduced the ... -PharmaLive.com

Avandia as a Type 2 Prevention Tool?  Sep 18, 2006
But is rosiglitazone maleate (Avandia) the magic bullet for a global health crisis, or an expensive band-aid that gives us yet another reason not to invest in ... -dLife.com

Drug Reduces Type 2 Diabetes Risk 62 Percent for Those at Highest ...  Sep 18, 2006
The drug rosiglitazone maleate reduced the risk of developing type 2 diabetes by 62 percent relative to placebo for individuals determined to have "pre-diabetes ... -SeniorJournal.com

New Diabetes Drug Lowers the Risk of Disease  Sep 16, 2006
New diabetes drug Avandia (rosiglitazone maleate) has been effective to reduct the risk of developing type 2 diabetes, new study shows. ... -Toronto Daily News

Avandia® Patents Afford Protection Against Generic Competition  Sep 7, 2006
Generic pharmaceutical manufacturers should proceed with caution when developing generic versions of Avandia®, (Rosiglitazone maleate), according to experts ... -PR Web

New Drug may Cut Diabetes  Sep 18, 2006
At the end of the trial, 51 percent of the participants receiving the new drug, Avandia(R) (rosiglitazone maleate) returned to normal blood sugar levels ... -FemaleFirst.co.uk

Avandia Patents Afford Protection Against Generic Competition  Sep 6, 2006
5, 2006 – Generic pharmaceutical manufacturers should proceed with caution when developing generic versions of Avandia, (Rosiglitazone maleate), according to ... -PharmaLive.com

(PRN) - Dominion to Present at Bank of America Conference ... [+]  Sep 15, 2006
...[+]. (PRN) - ITPS Acquires Independent Sales Channel of NPC ... [+. PRN) - Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression From Pre-Diabetes To ... -Bolsamania.com

Video B-Roll Via Satellite - Landmark Diabetes Prevention Trial ...  Sep 15, 2006
3820 vertical >> STORY SUMMARY: In the Canadian-led largest diabetes-prevention trial ever conducted worldwide, Avandia(R) (rosiglitazone maleate) reduced the ... -CNW Telbec (Communiqués de presse)

Landmark Study Shows Avandia(R) (rosiglitazone Maleate) Is More ...  -  12 Dec 2006
Medical News Today (press release),Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate) reduced the risk of

Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More ...  -  Dec 4, 2006
PR Newswire (press release),4 /PRNewswire/ -- Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate)

Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More ...  -  Dec 4, 2006
PR Newswire (press release),Avandia (rosiglitazone maleate) Indication & Important Safety Information Avandia, along with diet and exercise, helps improve blood sugar control.

Novel Oral Platelet Growth Factor, Eltrombopag, To Be Evaluated In ...  -  Dec 10, 2006
Medical News Today (press release),Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia® (rosiglitazone maleate) reduced the risk of

Landmark study shows Avandia(R) controls type 2 diabetes longer ...  -  Dec 4, 2006
CNW Telbec (Communiqués de presse),25) Important Information regarding Avandia (rosiglitazone maleate) Rosiglitazone maleate (Avandia(R)) is indicated for use alone, or in combination with

Landmark study shows Avandia® is more effective than metformin or ...  -  Dec 5, 2006
PipelineReview.com (press release),2006 | Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia® (rosiglitazone maleate) reduced the

Sección internacional  -  Dec 4, 2006
Bolsamania.com,...(PRN) - Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type

FDA Approves Avandamet® (rosiglitazone Maleate And Metformin HCl) ...  Jul 16, 2006
GlaxoSmithKline announced today FDA approval of Avandamet ® (rosiglitazone maleate and metformin HCl) for use as initial treatment of type 2 diabetes as an ... -Medical News Today

Data Demonstrate Benefits of Initial Use of Rosiglitazone Maleate ...  Jun 21, 2006
Avandaryl is the only therapy available that combines a thiazolidinedione (TZD), rosiglitazone maleate -- separately marketed as Avandia® -- with a ... -DG News

FDA Approves Avandamet (Rosiglitazone Maleate and Metformin HCl) ...  Jul 11, 2006
PHILADELPHIA, PA -- July 11, 2006 -- GlaxoSmithKline announced today FDA approval of Avandamet(R) (rosiglitazone maleate and metformin HCl) for use as initial ... -DG News

GlaxoSmithKline Announces FDA Approval and the Launch of Avandamet ...  Jul 11, 2006
Blood Sugar Control PHILADELPHIA, July 11 /PRNewswire/ -- GlaxoSmithKline announced today FDA approval of Avandamet(R) (rosiglitazone maleate and metformin HCl ... -PR Newswire

Glaxosmithkline Says FDA Approves Avandamet As A Front-line ...  Jul 11, 2006
The company said Avandamet is the only combination of a thiazolidinedione, rosiglitazone maleate, and metformin HCl, with approved use as initial therapy of ... -Trading Markets

GlaxoSmithKline gets FDA approval for Avandament to treat type 2 ...  Jul 11, 2006
2 diabetes, the most common form of diabetes. Avandamet is a combination of two drugs: rosiglitazone maleate and metformin HCl. -Life Style Extra

Avandamet Approved for New Indication  Jul 12, 2006
The FDA has approved GlaxoSmithKline’s Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets for use in the initial treatment of type 2 diabetes ... -Facts and Comparisons



Committee for Medicinal Products for Human Use Summary of Positive ...  Apr 28, 2006
...two antidiabetic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: rosiglitazone maleate, a member ... - PharmaLive.com

Latest Issue Of Alzheimer's & Dementia Explores New Ideas For ...  Apr 23, 2006
...new hypothesis is supported by the results of 24-week randomized clinical trial of an unmarketed formulation of rosiglitazone maleate (Avandia, GlaxoSmithKline ... - Medical News Today





Major Canadian Type 2 Diabetes Study Shows Significant Improvement ...  Feb 21, 2006
TORONTO, CANADA -- February 21, 2006 -- Data from a major new Canadian primary-care study show that the combination of rosiglitazone maleate (Avandia®) and low ... - DG News

Type 2 Diabetes - GSK Announces Approval And Availability Of ...  Feb 2, 2006
GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose combination product for type 2 diabetes. ... - Medical News Today,

GlaxoSmithKline Announces the Approval and Availability of ...  Feb 1, 2006
PHILADELPHIA — GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose combination product for ... - Drug Newswire,

GSK debuts Avandaryl for diabetes in the USA  Feb 2, 2006
Avandaryl is based on GSK's Avandia (rosiglitazone maleate) and the active ingredient in Sanofi-Aventis' Amaryl (glimepiride), now generically available in the ... - Pharma Times (subscription),

GlaxoSmithKline Announces the Approval and Availability of ...  Feb 1, 2006
PHILADELPHIA, February 01, 2006 /PRNewswire-FirstCall/ -- GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride ... - PharmaLive.com

GlaxoSmithKline Announces the Approval and Availability of ...  Feb 1, 2006
1 /PRNewswire-FirstCall/ -- GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose combination ... - PR Newswire

Type 2 Diabetes - GSK Announces Approval And Availability Of ...  Feb 2, 2006
GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose combination product for type 2 diabetes. ... - Medical News Today

GlaxoSmithKline Announces the Approval and Availability of ...  Feb 1, 2006
PHILADELPHIA, PA -- February 1, 2006 -- GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose ... - DG News

GlaxoSmithKline Announces the Approval and Availability of ...  Feb 1, 2006
PHILADELPHIA — GlaxoSmithKline announces the availability of Avandaryl(TM) (rosiglitazone maleate and glimepiride), a new fixed-dose combination product for ... - Drug Newswire

GSK debuts Avandaryl for diabetes in the USA  Feb 2, 2006
Avandaryl is based on GSK's Avandia (rosiglitazone maleate) and the active ingredient in Sanofi-Aventis' Amaryl (glimepiride), now generically available in the ... - Pharma Times (subscription)

Glaxo's Type 2 diabetes combo drug OK'd  Feb 1, 2006
The new treatment combines into one tablet two already-marketed Glaxo products, Avandia -- thiazolidinedione (TZD), rosiglitazone maleate -- and Amaryl ... - United Press International

In fine health  Jan 8, 2006
...companies. The company has also recently received tentative US FDA approval for its anti-diabetic drug, Rosiglitazone Maleate tablets. ... - Business Standard

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional